Elgia Therapeutics

About:

Elgia Therapeutics is a biopharmaceutical company.

Website: https://elgiatherapeutics.com/

Top Investors: Viva BioInnovator, Xiamen Changrong Investment Management

Description:

Elgia Therapeutics is a biotechnology company that specializes in novel approaches for the treatment of chronic inflammatory and fibrotic diseases. It specializes in the fields of healthcare, therapeutics, pharmaceutical, and medicine. It is creating innovative medicines for debilitating chronic diseases. It has discovered how metabolic stress drives inflammation and fibrosis and has identified untapped protein targets for small molecule drug discovery.

Total Funding Amount:

$2.33M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)elgiatherapeutics.com

Founders:

Adam Renslo, Alan Saltiel, Ariel Feldstein, Michael Karin, Michelle Arkin

Number of Employees:

1-10

Last Funding Date:

2020-06-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai